HSP 58.01 Hospira Inc $HSP Hit a 52 week high of 5
Post# of 338542
Posted On: 11/13/2014 12:09:20 PM
HSP 58.01 Hospira Inc $HSP Hit a 52 week high of 58.25 Closing the day 09:45 at 58.01 -0.08 -0.14% With a day low of 58.15 and a total volume of 12,371.
HSP Recent Posts: http://investorshangout.com/Hospira-Inc-HSP-51354/
HSP Hospira Inc Recent Headline News
Earnings Triple Plays
Bespoke Investment Group - Seeking Alpha - Wed Nov 12, 1:54AM CST
The third quarter earnings season unofficially comes to an end on Thursday when Wal-Mart (NYSE: WMT ) reports earnings before the open. So far this earnings season, more than 2,000 companies have reported their quarterly numbers, and our job here is...
GD: 143.11 (+1.81), ACT: 242.81 (+2.19), CBG: 32.65 (-0.06), HCP: 43.73 (+0.43), BCR: 165.94 (+0.73), PCG: 49.93 (-0.21), AMGN: 160.03 (-1.90), CB: 101.67 (+0.15), SRE: 110.13 (-0.52), PLD: 41.12 (+0.12), HSP: 57.91 (-0.18), TWX: 79.00 (+1.32), KIM: 24.81 (+0.21), CMI: 144.62 (-1.87), ALXN: 191.87 (-1.82), ESS: 201.29 (+0.85), ABBV: 63.94 (+0.18), CAT: 101.59 (-1.40), AAPL: 113.11 (+1.86)
Amgen's brodalumab beats Stelara in Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:52PM CST
CANF: 2.70 (+0.16), JNJ: 108.95 (+0.20), IDRA: 2.48 (-0.08), DERM: 16.00 (-0.25), MRK: 59.72 (+0.41), PFE: 30.47 (+0.05), AZN: 74.63 (+0.37), AMGN: 160.03 (-1.90), GSK: 45.71 (+0.09), HSP: 57.91 (-0.18), NVS: 94.52 (+1.86), CELG: 107.16 (-1.09)
Hospira Inc.'s Third-Quarter Earnings: The 3 Key Takeaways
Leo Sun, The Motley Fool - Motley Fool - Fri Nov 07, 10:53AM CST
Shares of Hospira jumped nearly 7% on Nov. 6 after the maker of injectable drugs and infusion technologies reported impressive third-quarter earnings. Source: Wikimedia Commons. Hospira's revenue climbed 2% year over year to $1.2 billion,...
HSP: 57.91 (-0.18)
Stock Market News for November 07, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:10AM CST
Benchmarks ended in the green zone yesterday following ECB President Mario Draghi’s statement regarding possible expansion of monetary stimulus by the European Central Bank
DHI: 24.27 (+0.26), WFM: 46.45 (-1.03), TSLA: 252.94 (+3.84), LEN: 45.55 (-0.01), QCOM: 70.55 (+0.26), PHM: 20.77 (+0.08), TOL: 33.67 (+0.16), GNW: 9.22 (+0.42), HSP: 57.91 (-0.18)
Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 83.95 (-0.78), ABAX: 55.10 (+0.90), GWPH: 75.46 (+0.14), HSP: 57.91 (-0.18)
Look for Shares of Hospira to Potentially Pullback after Yesterday's 6.67% Rise
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 57.91 (-0.18)
Watch for Hospira to Potentially Pullback After Gaining 6.67% Yesterday
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 57.91 (-0.18)
Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 196.39 (-0.12), ABAX: 55.10 (+0.90), ABBV: 63.94 (+0.18), HSP: 57.91 (-0.18)
Hospira (HSP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 12:39PM CST
The following Hospira (HSP) conference call took place on November 6, 2014, 09:00 AM ET. This is a transcript of that earnings call:
HSP: 57.91 (-0.18)
Hospira's (HSP) CEO Michael Ball on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 12:20PM CST
HSP: 57.91 (-0.18)
Hospira Q3 income up big
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:11AM CST
HSP: 57.91 (-0.18)
Hospira (HSP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:55AM CST
HSP: 57.91 (-0.18)
Hospira unveils generic Paricalcitol Injection in three multi-dose sizes
M2 - Thu Nov 06, 7:28AM CST
Injectable drug company
HSP Recent Posts: http://investorshangout.com/Hospira-Inc-HSP-51354/
HSP Hospira Inc Recent Headline News
Earnings Triple Plays
Bespoke Investment Group - Seeking Alpha - Wed Nov 12, 1:54AM CST
The third quarter earnings season unofficially comes to an end on Thursday when Wal-Mart (NYSE: WMT ) reports earnings before the open. So far this earnings season, more than 2,000 companies have reported their quarterly numbers, and our job here is...
GD: 143.11 (+1.81), ACT: 242.81 (+2.19), CBG: 32.65 (-0.06), HCP: 43.73 (+0.43), BCR: 165.94 (+0.73), PCG: 49.93 (-0.21), AMGN: 160.03 (-1.90), CB: 101.67 (+0.15), SRE: 110.13 (-0.52), PLD: 41.12 (+0.12), HSP: 57.91 (-0.18), TWX: 79.00 (+1.32), KIM: 24.81 (+0.21), CMI: 144.62 (-1.87), ALXN: 191.87 (-1.82), ESS: 201.29 (+0.85), ABBV: 63.94 (+0.18), CAT: 101.59 (-1.40), AAPL: 113.11 (+1.86)
Amgen's brodalumab beats Stelara in Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:52PM CST
CANF: 2.70 (+0.16), JNJ: 108.95 (+0.20), IDRA: 2.48 (-0.08), DERM: 16.00 (-0.25), MRK: 59.72 (+0.41), PFE: 30.47 (+0.05), AZN: 74.63 (+0.37), AMGN: 160.03 (-1.90), GSK: 45.71 (+0.09), HSP: 57.91 (-0.18), NVS: 94.52 (+1.86), CELG: 107.16 (-1.09)
Hospira Inc.'s Third-Quarter Earnings: The 3 Key Takeaways
Leo Sun, The Motley Fool - Motley Fool - Fri Nov 07, 10:53AM CST
Shares of Hospira jumped nearly 7% on Nov. 6 after the maker of injectable drugs and infusion technologies reported impressive third-quarter earnings. Source: Wikimedia Commons. Hospira's revenue climbed 2% year over year to $1.2 billion,...
HSP: 57.91 (-0.18)
Stock Market News for November 07, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:10AM CST
Benchmarks ended in the green zone yesterday following ECB President Mario Draghi’s statement regarding possible expansion of monetary stimulus by the European Central Bank
DHI: 24.27 (+0.26), WFM: 46.45 (-1.03), TSLA: 252.94 (+3.84), LEN: 45.55 (-0.01), QCOM: 70.55 (+0.26), PHM: 20.77 (+0.08), TOL: 33.67 (+0.16), GNW: 9.22 (+0.42), HSP: 57.91 (-0.18)
Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 83.95 (-0.78), ABAX: 55.10 (+0.90), GWPH: 75.46 (+0.14), HSP: 57.91 (-0.18)
Look for Shares of Hospira to Potentially Pullback after Yesterday's 6.67% Rise
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 57.91 (-0.18)
Watch for Hospira to Potentially Pullback After Gaining 6.67% Yesterday
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 57.91 (-0.18)
Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 196.39 (-0.12), ABAX: 55.10 (+0.90), ABBV: 63.94 (+0.18), HSP: 57.91 (-0.18)
Hospira (HSP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 12:39PM CST
The following Hospira (HSP) conference call took place on November 6, 2014, 09:00 AM ET. This is a transcript of that earnings call:
HSP: 57.91 (-0.18)
Hospira's (HSP) CEO Michael Ball on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 12:20PM CST
HSP: 57.91 (-0.18)
Hospira Q3 income up big
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:11AM CST
HSP: 57.91 (-0.18)
Hospira (HSP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:55AM CST
HSP: 57.91 (-0.18)
Hospira unveils generic Paricalcitol Injection in three multi-dose sizes
M2 - Thu Nov 06, 7:28AM CST
Injectable drug company
(0)
(0)Scroll down for more posts ▼